期刊文献+

草酸铂联合氟尿嘧啶及亚叶酸钙治疗26例晚期胃癌临床观察 被引量:1

Clinical observation of Oxaliplatin combined with 5-FU/FA treatment of patients with advanced stomach cancer
下载PDF
导出
摘要 目的研究草酸铂(OXA)、氟尿嘧啶(5-FU)及亚叶酸钙(CF)联合化疗对晚期胃癌的临床疗效及其毒副作用。方法对26例晚期胃癌患者采用OXA130mg/m2静脉滴注2hdl,CF200mg/m2静脉滴注2hdl-5,5-FU300mg/m2静脉滴注4hdl-5、3周为1周期,对照组25例治疗方案采用顺铂(DDP),和氟尿嘧啶,3周为1周期,均连用3周期后评定疗效,按WHO标准进行疗效评定。结果试验组共治疗26例,PR13例,SD8例,PD5例,有效率为50%,对照组有效为28%,不良反应主要为感觉神经毒性,胃肠道反应,血液毒性轻微。结论OXA+5+FU+CF是治疗晚期胃癌安全有效的方案。 [Objective] To evaluate the efficacy and adverse effects of Oxaliplatin combined with 5-Fluorouracil (5-FU)ffolinic acid(FA) treatment of patients with advanced stomach cancer. [Methods] 26 patients with advanced stomach cancer OXA 130 mg/m^2 iv infusion for 2 h dl, CF 200 mg/m^2 iv infusion for 2 h, dl-d5, 5-FU 300 mg/m^2 iv infusion for 4 h, dl-d5, repited every 3 weeks. Tumor assessment was done after 3 cycles. [Results] 26 patients with PR 13 cases, SD 8 cases, PD 5 cases were studied. The overall response rate was 50%. The overall response rate of the control was 28%. The main adverse effect was neurosensory toxicity. [Conclusion] It is safe and effective to use Oxaliplatin combined with -5FU/FA treatment to patients with advanced stomach cancer.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2006年第17期2626-2628,共3页 China Journal of Modern Medicine
关键词 胃肿瘤 草酸铂 氟尿嘧啶 亚叶酸钙 stomach cancer Oxaliplatin 5-FU FA
  • 相关文献

参考文献12

二级参考文献15

  • 1孙燕 周际昌.临床肿瘤内科手册(第二版)[M].北京:人民卫生出版社,1996.18-26. 被引量:3
  • 2金懋林.中国临床肿瘤学教育专辑[M].北京:中国医药科技出版社,2000.143-154. 被引量:1
  • 3[1]Raymond E,Faivre S,Woynarowski JM,et al.Oxaliplatin:mechanism of action and antineoplastis activity.Sem Oncol,1998,2:4-12. 被引量:1
  • 4[2]Wiseman LR.Oxaliplatin:a review of its use in the management of Metastatic colorectal cancer.Drugs & Aging,1999,14:459-475. 被引量:1
  • 5[3]Bismuth H,Adam R,Levi F,et al.Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant.Ann Surgery, 1996,224:509-522. 被引量:1
  • 6[1]Choo JX,Cheah J. Efectiveness of clinical pathways in improving. The Quality of Care. Singapore Nursing Journal,1999,27:8-11. 被引量:1
  • 7[2]Healy WL,Iorio R. Impact of cost reduction programs on short-term patient outcome and hospital cost of total knee arthroplasty. Bone Joint Surg Am, 2002 ,84-A(3):384-393. 被引量:1
  • 8[3]Thomas R, Gadacz MD. General surgical clinical pathways: an introduction. The American Surgeon, 1997, 63(1):107-110. 被引量:1
  • 9[5]Clinical pathways for general surgeons: cholecystectomy, open W/O CBDE. The American Surgeon, 1998, 64(3): 289- 292. 被引量:1
  • 10[7]Restuccia JD, Paync SMC, Lenhart G, et al. Assessing the appropriateness of hospital utilization to improve efficiency and competitive position. Health Care Managament Review,1987,12: 17-27. 被引量:1

共引文献232

同被引文献14

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部